29
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Long Term Dental Work Force Build-Up and DMFT-12 Improvement in the European Region

      editorial

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Introduction As Mikiko Hayashi noticed in an amazingly poetic way, dentistry remains in majority of national health systems across the globe: “the Cinderella of health care.” Regardless of undisputed progress of scientific knowledge there is a growing gap in service utilization patterns among the world's rich and poor citizens. The first tend to consume much of a rather cosmetic expensive treatments without essential health added value. At the same time almost three billion of people belonging to the low income households, lack access to basic dental services or do not pay a visit to a dentist for years (Hayashi et al., 2014). Although the issue of affordability is high at stakes in these countries, uneven distribution between rural and urban areas adds to the challenge. Prime example is definitely India whose giant population was served by 117,825 registered dentists out of whom almost 90,000 were concentrated in only four out of thirty Indian federal states (Vundavalli, 2014). Another case is Australia with its huge geographic area and recently reported ratio of almost 40,000% differential between dentist density in the suburbs of core coastline cities and desert Aboriginal communities (Tennant et al., 2013). Due to international efforts addressing global oral health deficiencies national capacities worldwide have increased sharply over past few decades (Petersen, 2003). Important part of this capacity build-up was grounds laid down by establishment of “WHO Oral Health Country/Area Profile Programme” (or “CAPP”) by the World Health Organization (WHO) back in 1990s. Its cause was the fact that evidence based policy needed reliable and internationally comparable field data. The two main WHO Collaborating Centers whom we own existence and maintenance of these public registries are the Niigata University, Japan and Faculty of Odontology, Malmö, Sweden. The first is in charge of Periodontal Country Profiles and the latter pursues the uneasy task of providing broader Country Oral Health Profiles. Nevertheless other comprehensive sources of evidence on oral health status across regions and nations developed independently. FDI World Dental Federation provides access to the its own Data Hub which consists of fusioned national data sources originating from WHO and World Bank (WB) and Globocan official registries. The European Health for All database (HFA-DB) created and updated by the WHO Office for the European Region and refers to a total of 53 countries located in the European continent. Some of the aforementioned investments allowed for revelation of hidden long term national patterns in oral health care and identification of core weaknesses that might serve as appropriate policy targets in future. So far there is scarcity of published evidence comparing efficiency of all European countries in dental workforce build-up and its relationship to the dental health status of school children in a several decades long time horizon. Methodology Measurements we relied on in this study were averaged over country populations in an observed year. Source used was official release of European Health for All Database (HFA-DB). Targeted 53 countries were all located entirely or partially within the WHO geographical boundaries of the European region. Indicators of health care professional personnel capacity (dentist density and graduate dentist annual outputs) and DMFT-12 (Decayed/Missing/Filled Teeth at 12 year olds) as the core indicator of juvenile oral health were observed. Selected indicators are presented in Tables 1, 2. Total decrease of DMFT-12 and total increase in dentist density per 100,000 population were observed as entire span between the first and the last available value reported to WHO by the national authorities. These historical indicator differentials were used to sort out countries through a top-down approach from most successful to the less efficient ones. Table 1 Oral health indicator DMFT-12 in the European region according to national values reported to WHO HFA-DB. Countries First available DMFT-12 index Last available DMFT-12 index Time span between two observations (Years) Total DMFT—12 decrease Annual DMFT—12 decrease Sweden 7.81975 0.82011 36 7.00 0.194 Norway 8.4 1973 1.62006 33 6.80 0.206 Finland 6.91975 0.72009 34 6.20 0.182 Netherlands 7.31974 1.12005 31 6.20 0.2 Switzerland 6.11975 0.822009 34 5.28 0.155 Slovenia 6.91984 1.82000 16 5.10 0.319 Denmark 5.21975 0.62012 37 4.60 0.124 Italy 5.51978 1.12004 26 4.40 0.169 Ireland 5.41970 1.12002 32 4.30 0.134 United Kingdom 4.71973 0.72009 36 4.00 0.111 Hungary 6.11976 2.42008 32 3.70 0.116 EU members before May 2004 4.741980 1.372000 20 3.37 0.168 Slovakia 5.7 1975 2.42006 31 3.30 0.106 Germany 3.91992 0.72009 17 3.20 0.188 Latvia 6.61985 3.42004 19 3.20 0.168 Portugal 4.61975 1.482005 30 3.12 0.104 Czech Republic 5.7 1975 2.62006 31 3.10 0.1 Luxembourg 3.91985 0.82006 21 3.10 0.148 Croatia 7.61986 4.82010 24 2.80 0.117 Greece 3.81975 1.352007 32 2.45 0.076 France 3.51975 1.22006 31 2.30 0.074 EU 4.11985 1.862000 15 2.24 0.149 Belgium 3.11972 0.92010 38 2.20 0.058 Albania 5.91983 3.82007 24 2.10 0.087 Bosnia and Herzegovina 6.21997 4.22004 7 2.00 0.286 Kyrgyzstan 3.11973 1.11993 20 2.00 0.1 Uzbekistan 2.81988 0.92001 13 1.90 0.146 Estonia 4.11988 2.42000 12 1.70 0.142 European Region 3.811985 2.222000 15 1.59 0.106 Cyprus 2.5 1990 1.32010 20 1.20 0.06 Bulgaria 4.21979 3.12008 29 1.10 0.038 Malta 2.31975 1.42004 29 0.90 0.031 Spain 1.91975 1.12010 35 0.80 0.023 Turkey 2.71987 1.92007 20 0.80 0.04 Israel 2.41975 1.66 2002 27 0.74 0.027 EU members since May 2004 4.221985 3.552000 15 0.67 0.045 Russian Federation 3.51975 2.92008 33 0.60 0.018 Commonwealth of Independent States (CIS) 3.491986 3.461990 4 0.03 0.007 Armenia 2.41985 2.41990 5 0.00 0 Georgia 2.41985 2.41990 5 0.00 0 Kazakhstan 2.11985 2.11990 5 0.00 0 Montenegro 3.42006 3.42006 0 0.00 0 San Marino 3.71987 3.71990 3 0.00 0 Tajikistan 1.21973 1.21990 17 0.00 0 Turkmenistan 2.61985 2.61990 5 0.00 0 Lithuania 3.61985 3.72005 20 −0.10 −0.005 Ukraine 2.51983 2.82008 25 −0.30 −0.012 TFYR Macedonia 6.51986 6.92007 21 −0.40 −0.019 Romania 1.71975 2.192009 34 −0.49 −0.014 Republic of Moldova 2.31986 3.52008 22 −1.20 −0.054 Andorra N/A N/A N/A N/A N/A Austria N/A 1.42007 N/A N/A N/A Azerbaijan N/A N/A N/A N/A N/A Belarus N/A 2.12009 N/A N/A N/A Iceland N/A 1.42005 N/A N/A N/A Monaco N/A N/A N/A N/A N/A Poland N/A 3.22010 N/A N/A N/A Serbia N/A N/A N/A N/A N/A *DMFT-12 index—Decayed, missing or filled teeth at age 12. Table 2 Dentist density and graduate dentist output in the European region according to the national values reported to WHO HFA-DB. Countries Dentists density (PP) per 100 000 (First available/Last available) Time span between two observations (Years) Total increase in Dentist Density (PP) per 100 000 Annual increase in Dentist Density (PP) per 100 000 Dentists graduated per 100 000 (First/Last available value) Number of Dentists (PP) national level (First/Last available value) Number of dentists graduated in a given year (First/Last available value) Portugal 11.01980/76.82011 31 65.8 2.12 0.51985/6.92011 10831980/81082011 501985/7232011 Cyprus 35.81980/91.52011 31 55.7 1.80 N/A 1821980/7832011 N/A TFYR Macedonia 23.61980/78.62011 31 55 1.77 3.81980/7.62010 4461980/16222011 721980/1562010 Spain 10.51980/63.02011 31 52.5 1.69 1.01991/3.02011 39461980/290702011 3691991/13792011 Greece 79.31980/128.52011 31 49.2 1.59 4.31980/3.22007 76461980/145182011 4121980/3552007 Luxembourg 36.01980/83.12012 32 47.1 1.47 N/A 1311980/4412012 N/A Estonia 46.21980/88.02011 31 41.8 1.35 1.61980/2.32011 6821980/11792011 231980/312011 Bulgaria 54.61980/90.92011 31 36.3 1.17 2.61985/4.02011 48391980/66822011 2311985/2902011 Belarus 17.91980/54.12011 31 36.2 1.17 1.81990/2.62011 17241980/51232011 1871990/2452011 Austria 21.61980/56.92012 32 35.3 1.10 0.01998/1.62010 16221980/47972012 31998/1312010 Croatia 37.41980/71.82011 31 34.4 1.11 3,71980/3.52003 17151980/31622011 1691980/1562003 Latvia 37.01992/70.72011 19 33.7 1.77 2.51980/1.82012 9661992/14562011 621980/372012 Romania 31.71999/62.12011 12 30.4 2.53 1.91991/5.92011 71081999/133242011 4461991/12632011 Ireland 30.41980/58.02012 32 27.6 0.86 2.11980/1.52011 10331980/26612012 711980/702011 Lithuania 55.21992/82.12011 19 26.9 1.41 1.51985/4.72011 20441992/24862011 541985/1412011 Hungary 26.41985/52.52011 26 26.1 1.00 1.31985/2.82011 28081985/52362011 1341985/2792011 Czech Republic 45.91980/70.82011 31 24.9 0.80 4,31980/2.92011 47431980/74292011 4401980/3002011 Ukraine 45.42000/67.62012 12 22.2 1.85 2.82000/4.52012 223722000/306882012 14012000/20452012 Armenia 23.02000/42.72012 12 19.7 1.64 0.71980/20.22012 7422000/12902012 221980/6102012 EU 48.21985/67.02011 26 18.8 0.72 2.31980/2.72011 N/A N/A EU members before May 2004 53.61992/71.32011 19 17.7 0.93 2.31985/2.42011 N/A N/A Italy 42.21993/59.32011 18 17.1 0.95 0.71985/2.22011 240001993/351832011 4101985/13092011 Germany 65.11992/80.12011 19 15 0.79 3.11991/2.72011 524561992/655022011 24441991/21872011 European Region 28.61980/42.52011 31 13.9 0.45 2.01985/2.32011 N/A N/A Republic of Moldova 33.71980/46.92012 32 13.2 0.41 1.81980/3.42011 13531980/16702012 701980/1222012 Turkey 15.91980/28.42011 31 12.5 0.40 0.71980/1.32011 70771980/210992011 3191980/9502011 Andorra 48.41995/60.52009 14 12.1 0.86 2.92003/0.02009 311995/512009 22003/02009 Iceland 73.71980/84.22012 32 10.5 0.33 3.11980/1.92010 1681980/2702012 71980/62010 Kazakhstan 30.91980/41.22012 32 10.3 0.32 1.81990/2.42009 46231980/69202012 3061990/3742009 Netherlands 41.01995/50.22010 15 9.2 0.61 3.11985/1.72011 63441995/83452010 4531985/2782011 Switzerland 45.01980/53.62011 31 8.6 0.28 2.11980/1.42011 28411980/41232011 1301980/1042011 Albania 24.91980/32.92006 26 8 0.31 1.01990/1.32010 6651980/10352006 331990/422010 EU members since May 2004 44.21980/51.42011 31 7.2 0.23 2.31980/3.32011 N/A N/A Belgium 63.61985/70.42011 26 6.8 0.26 1.41993/1.32011 62731985/77772011 1391993/1462011 Commonwealth of Independent States (CIS) 24.81980/30.82012 32 6 0.19 2.01990/2.52012 N/A N/A Slovakia 44.12000/50.02007 7 5.9 0.84 2.61980/1.02009 23842000/26972007 1301980/532009 United Kingdom 48.32007/53.62012 5 5.3 1.06 N/A 294512007/336532012 N/A Tajikistan 11.81985/15.92011 26 4.1 0.16 1.01990/0.72006 5391985/12442011 551990/432006 Russian Federation 28.51990/32.02006 16 3.5 0.22 2.01990/1.82004 421021990/456282006 29301990/25672004 Uzbekistan 13.81980/17.32012 32 3.5 0.11 1.31990/1.32010 21951980/51512012 2551990/3772010 Slovenia 59.11998/62.42011 13 3.3 0.25 0.81980/1.92011 11711998/12802011 161980/382011 Norway 82.21985/85.22011 26 3 0.11 2.51980/2.72011 34141985/42182011 1011980/1352011 Kyrgyzstan 15.31980/17.82012 32 2.5 0.08 1.11980/4.82012 5541980/9732012 381980/2622012 Malta 43.22009/45.32012 3 2.1 0.7 2.81990/1.42012 1792009/1902012 101990/62012 Bosnia and Herzegovina 19.51980/20.72010 30 1.2 0.04 1.81980/3.42010 7991980/7972010 741980/1322010 Georgia 33.21996/33.62012 16 0.4 0.02 1.01990/7.62011 15341996/15092012 551990/3402011 France 65.62011/65.32012 1 −0.3 −0.3 3.41980/1.42007 415072011/417402012 18491980/8362007 Azerbaijan 28.91980/26.72012 32 −2.2 −0.07 1.31990/1.22012 17771980/24612012 891990/1132012 Turkmenistan 16.71998/11.92012 14 −4.8 −0.34 1.61985/0.32012 7881998/6142012 511985/142012 Finland 85.22000/78.92010 10 −6.3 −0.63 3.51980/3.32012 44102000/42342010 1661980/1772012 Sweden 91.21995/84.92010 15 −6.3 −0.42 4.41980/2.32010 80481995/79592010 3621980/2172010 Denmark 84.61992/77.92009 17 −6.7 −0.39 3.21980/2.52011 43731992/42972009 1661980/1412011 Israel 85.61996/75.62011 15 −10 −0.66 1.41990/1.22011 48671996/58672011 671990/902011 Serbia 47.02003/34.12012 9 −12.9 −1.43 2.92002/7.62011 35162003/24582012 2162002/5502011 Monaco 115.41980/102.42012 32 −13 −0.41 0.02011/0.02011 301980/372012 02011/02011 Poland 47.31980/33.82011 31 −13.5 −0.43 2.11980/2.52011 168341980/130332011 7401980/9582011 Montenegro 26.21980/4.52011 31 −21.7 −0.7 N/A 1521980/282011 N/A San Marino N/A N/A N/A N/A N/A N/A N/A *Ranking was based on average annual improvement to eliminate bias arising from different reporting periods. Results Combined insight into the national professional capacity data reveals few interesting patterns (Table 1). Over the past three decades, dentist density per 100,000 resident population increased sharply across Europe. The list is topped by mostly Mediterranean countries (Portugal, Cyprus, Spain, Greece), continental high-income economies (Luxemburg and Austria) while the remaining ones among top 10 performers belong to Eastern European formerly planned economies (TFYR Macedonia, Estonia, Bulgaria, Belarus). Surprisingly, the upper half of ranked dental health systems is actually dominated by Eastern European countries out of which some are post-2004 EU members (Croatia, Latvia, Romania, Lithuania, Hungary, Czech Republic) others belonged to the Commonwealth of Independent States (CIS) for the most of post Cold War period (Ukraine, Armenia, Republic of Moldova, Kazakhstan). Few regions in Europe actually recorded fall in professional staff density. This was either the case due to satisfactory health system performance such as the Nordic model applied in Finland, Sweden and Denmark. Other countries with significant negative trend noticed where two Western Balkan countries (Serbia and Montenegro), Poland and CIS members Turkmenistan and Azerbaijan. Among these there are few traditional mature market economies of France, Israel and Monaco. Observation of European historical evolution on DMFT-12 since the middle of 1970s has shown substantially different landscape (Table 2). The list is topped by Scandinavian countries (Sweden, Norway, Finland and Denmark). All other top ten nations marked by high childhood dental health improvements belong to traditional high income societies (Netherlands, Switzerland, Italy, Ireland, and United Kingdom) or recent ones like Slovenia. The remaining part of upper half of the rank list is dominated by diverse Eastern European countries (Hungary, Slovakia, Latvia, Croatia, Czech Republic, Albania, Bosnia and Herzegovina, Kyrgyzstan, Uzbekistan, Estonia) with quite few OECD members prior to 2000s (Germany, Luxembourg, Greece, France, Belgium, Portugal). Large amount of missing DMFT-12 data in certain years or geographical territories or rather short intervals observed placed significant part of bottom ranked countries into the “no-progress” group (equal values reported at baseline and last point in seven countries) with eight countries with non-applicable DMFT-12 calculation. Five nations confirmed worsening of childhood dental health at age 12 and these were Lithuania, Ukraine, TFYR Macedonia, Romania, Republic of Moldova. Vast majority of the entire aforementioned group of non-classified or poor performing health systems are located within Eastern Europe and the Balkans region. Discussion With regards to core oral health indicators such as the index of serious tooth decay (DMFT) most of broad European Region recorded significant achievements since very concerning dental health landscape of the 1970s. Deep Russian recession of 1990s dragging surrounding nations and transitional health reforms taking place throughout Central and Eastern Europe took their toll (Jakovljevic and Getzen, 2016). Nevertheless since the late 1990s things got substantially better in many of these countries, availability of resources became bigger while management of both in- and outpatient dental services was getting more efficient and cost-effective toward the 2000s (Jakovljevic, 2013). These developments affected both the old public and newly evolving, private dental sector. Over several decades improvements in school children were huge. Such advances mostly assumed decreasing frequency of tooth extractions substituted with fillings as well as longer preservation of natural teeth in adults alongside life span. Although there is an evident converging trend in oral health within the European Union (EU) member states few core weaknesses remain. Some of the most prominent are: inter country and inter regional diversity of dental health status indicators among the elderly, lower affordability of dental care to minority groups and the poor and concerning signs of possible worsening of oral health among the European children since the 2000s (Bourgeois et al., 2003). Blossoming of private dental schools in less regulated markets, oversupply and underemployment of graduate dentists are present but more characteristic of Post-Semashko, Eastern European national systems. Some policy makers across the region suspected falling quality of medical services. This might be partially attributable to the growing competitiveness of the private dental sector in Europe and financial incentives to gain larger profit margins. Previous literature records suspect direct causal link between DMFT-12 and dentist density. Furthermore there is reliable evidence that pediatric dental health is less linked to the local accessibility of dental practitioners and more dependent upon gross national income level, dental expenditure and expected years of education (Pinilla and González, 2009). Nevertheless availability of these data over long term time horizon allows assessment of independent progress in both issues in Europe. Oversight of significant inter-country differences in dental workforce capacities across the continent to some extent masks huge regional intra-country diversity mostly driven by socioeconomic inequalities (Tchicaya and Lorentz, 2014). Contribution of European Commission's agenda in oral public health is development of strategies aimed at closing major gaps in population dental status within the EU and converging national health policy targets (Widström and Van Den Heuvel, 2005). Recent FDI effort actually reveals hidden patterns of dental work force migration and market incentives affecting service provision and unmet demand (Yamalik et al., 2014). Output of dental graduates follows country size as a general rule (Table 1) and it is dominated by Russian Federation, Germany and other large European countries. Some others like Turkey exhibit so far weaker overall dentist practitioner capacity (21,099 in total in 2011 compared to its large population size). Some of similar time lags of the emerging economies compared to mature ones might be explained by the fact that oral health is frequently neglected policy priority in most national health systems (Kandelman et al., 2000). Study limitations Unique data set exploited for this study consisted of national level records reported to WHO HFA-DB. Unlike many other public health indicators present in major international publicly accessible registries, the best available oral health and dentist density data are presented with wide gaps in both individual countries as well as time periods. These missing data gaps are present in many years or entire regions. Therefore all calculations made here are based upon the best available evidence. Conclusions arising from presented facts are therefore based on differentials between the first and the last available data. In order to improve methodological soundness and applicability we presented individual country advances in community oral health in terms of annual rates and total differentials. Although these calculations might serve as an approximate success ratio they are not fully comparable among countries. This is the case because reported annual national values frequently refer to slightly different time horizons. Nevertheless majority of observed historical data belong to the middle of 1970s or early 1980s while most of the last available data belong to the early 2010s. Conclusion The long term trends observed relate to the period of three to four decades. Such insight points out to the broad changes of the landscape of major challenges in the European dentistry. Obvious successes in liquidating great oral health crisis of the 1970s are reflected in a decent dental status of European school children. Serious efforts to build up dental work force capacities are only partially responsible for that success story (Velickovic et al., 2015). Large part of the improvements is actually attributable to the growing living standards, oral health literacy of general population and policy efforts to improve affordability of dental care to the ordinary citizens (Rančić et al., 2015). Nevertheless major upcoming challenges are population aging associated with extended life expectancy and blossoming of prosperity diseases and increased demand for medical care by the elderly. How the European region will cope with these issues remains unclear (Ogura and Jakovljevic, 2014; Jakovljevic, 2015, 2016; Jakovljevic and Milovanovic, 2015). This study points out to the significant regional differences within the continent (Jakovljevic and Getzen, 2016). Eastern EU members as well as Commonwealth of Independent States members were driving the large part of staff density increase due to their intensive transitional health reforms (Jakovljevic et al., 2015). Regardless of such promising changes these countries will remain substantially more vulnerable to the upcoming challenges compared to the traditional market economies of Western Europe (Jakovljevic et al., 2016a,b). Author contributions MJ and TK designed the research questions and concept of this Opinion article. ML and RV acquired selected published data from the public registry European Health for All Database issued by WHO. All four authors interpreted jointly the findings stated in the article and contributed to the final manuscript in important intellectual content. Conflict of interest statement The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

          Related collections

          Most cited references16

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Growing Burden of Non-Communicable Diseases in the Emerging Health Markets: The Case of BRICS

          Historical Perspective on Non-Communicable Diseases Worldwide The blooming of incidence and prevalence of “prosperity diseases” among the broad layers of modern day populations is rather novel phenomenon in demographic history of the human race (1). Illnesses such as obesity (2), diabetes mellitus, hypertension, cerebrovascular and cardiovascular consequences of atherosclerosis, renal insufficiency, mental disorders, and even cancer are closely related to the increased longevity of most contemporary societies (3). In previous centuries, they were mostly reserved for elite social groups enjoying rather luxurious life style. Vast majority of citizens of the time were living in rural communities on the verge of poverty. Their structure of morbidity even in Europe until late 19th century was dominated by burden of infectious diseases and injury while neonatal and maternal mortality rates were huge. Industrial revolution led to the growth of living standards, invention of vaccines, and antibiotics, and ultimately development of organized publicly funded health systems. The prominent European health policy makers in the 19th century properly believed that effective public health measures will diminish huge burden of infectious diseases. Consecutively, they expected that overall costs of medical care provision should decrease substantially and ultimately reach plateau level. This second step turned out to be a great miscalculation and a surprise. Like no time in written past, people began living longer and healthier lives. But it happened at the cost. Simultaneously, from many industrialized nations, evidence were accumulating of accelerated occurrence of non-communicable diseases. Accomplishment of evidence-based medicine succeeded to control many of these initially incurable diseases, thereby transforming them into life time disorders as in the typical cases of diabetes and terminal renal insufficiency. Acute bacterial infections, dominating morbidity in the old days, were usually successfully treated within few weeks. Unlike these, chronic illnesses were bringing long-term burden for both the patients and the society. Malignant disorders with its complex treatment strategies present particularly demanding medical conditions. Cancer leaves permanent footprint in a life of a patient in terms of poor survival rates, decreased life quality, and working ability. Non-Communicable Diseases Expansion in Developing Countries The ultimate demographic transition consisting of ascending portion of elderly, falling fertility rates, and bold growth of median age within contemporary nations became broadly recognized as population aging (4). Most of this transformation of morbidity and mortality structure happened in rich industrial countries of Western Europe, North America, and Japan many decades ago. The same pattern of population aging associated with huge incidence and prevalence rates of major non-communicable diseases repeated on wider scale much later in developing countries. The worldwide transformation of public health landscape to the large extent is attributable to the accelerated pace of globalization after the end of Cold War era (5). Particularly interesting, current developments belong to the economies responsible for most of global growth that are recognized as the emerging markets. The countries whose reshaped structure of morbidity is most likely to affect global health in the future are definitely the BRICS [Brazil (6), Russia, India, China, South Africa] (7). BRICS’s far extended long-term influence in health arena worldwide will be related to their mammoth sized populations. Their increased domestic demand for medical technologies and medicines is already shaping investment strategies of major pharmaceutical and medicinal device industries. Another significant issue is their bold foreign medical assistance programs particularly targeted for emerging markets of Sudanese Africa, Latin America, Central and South East Asia (8). These leading countries are closely followed by a set of smaller scale economies mostly marked as N-11 (Bangladesh, Egypt, Indonesia, Iran, South Korea, Mexico, Nigeria, Pakistan, the Philippines, Turkey, and Vietnam) (9). Very similar process is simultaneously taking place in dynamically developing Southern (10) and South-East Asian (11), Latin American, Eastern European (12), and Arab speaking MENA region (13). Eradication of poverty currently taking place in these regions is coupled with changed dietary habits (14) (higher salt and fat and lower carbohydrate intake), wide spread tobacco abuse, and sedentary life styles (15). The mentioned factors contributing to the growing burden of non-communicable diseases. It became obvious that contribution of emerging markets and Third World countries to the global economic burden of NCDs will grow further. It will, highly, likely, soon have greater share than the one of established mature market economies (16). As basic assumption of most forecasts remains the fact that such growth will be dominated by developments in China (17) and India (18). High toll of this unfortunate change for developing countries is coupled impact of communicable and non-communicable diseases (19). At the same time, many national health systems throughout Asia and beyond expose poor responsiveness to the NCDs related population needs. There seems to be serious barriers in access to medical care and its affordability to the ordinary citizens. The increasing awareness on approaching of almost unbearable burden of NCDs (20) led to the high profile United Nations meeting on the subject in 2011 (21). Such UN gatherings are so uncommon on health related topics that it happened only once in past due to AIDS. NCDs recognized as the core global health challenges were cardiovascular disorders, cancer, diabetes, and chronic respiratory illness. These changes are beginning to profoundly change the landscape of even the poorest countries around the globe. So far, NCDs have already overarched burden of infectious diseases and injury in terms of disability adjusted life years, as well as work load and economic burden to the most national health sectors (22). Promising Cost-Effective Solutions for the Future The blossoming of prosperity disease did not happen suddenly. It was a consequence of long chain of evolutionary events in civil society development. We will mention only some of them such as technological revolution, improved housing conditions, sanitation and sewage disposal, public health successes in eradication of major infectious diseases, policy efforts to tackle hunger and starvation among the world’s poor, and ultimately tobacco (23) and alcohol abuse (24). As its preconditions took so long to be created, it is unlikely that we shall be able to tackle NCD’s burden effectively in near future. Rich countries as well as developing ones concluded that orchestrated efforts will be needed in the international arena. World Health Organization has adopted a package of measures, whose implementation and progress are being monitored (25), broadly known as “Global coordination mechanisms on NCDs” (26). As most cost-effective and feasible measures were identified, control of tobacco consumption to the targeted 5% consumers worldwide until 2025 and reduction of salt intake by general populations of at least 15% in the order of significance. These interventions that were named “best buy” solutions offering best attainable compromise between the need for investment and outcomes that will be gained (27). Promotion of active life style and healthy diet, as well as other preventive and screening measures, comes at the second place. If such efforts are followed closely by national authorities, WHO expects that these measures should achieve 25% reduction of NCD attributable premature mortality until 2025 (28). Many of the proposed strategies were previously tested within a sound methodological framework applied on a second largest emerging market of the America, Mexico (29). The most challenging issue for the emerging markets’ health systems appears to be universal health coverage (30). These systems were built up on diverse historical legacies and should find each one its own way to handle the upcoming pressure of prosperity diseases coupled with accelerated population aging. Profound transformation of current network of medical facilities in Third World countries, as well as human capacity building, will be forced to move priority from acute care toward complex, chronic illnesses (31). Growing Burden of NCDs Coincided with Increasing Health Expenditures As witnessed by current WHO estimates given in Table 1, we may see that overall burden of non-communicable disease has consolidated in some countries such as Russia recording even slight decrease over the past decade. Nevertheless, leading emerging markets of China and India followed by a large distance in absolute terms by Brazil and South Africa exhibited clear pattern of increasing burden of NCDs expressed in terms of Years of Life Lost, Years Lost due to Disability, and Disability-Adjusted Life Year (DALY). According to WHO, NCDs attributable mortality increased substantially among the same four countries with notable promising exception of Russia. Russian partial success in containing but not decreasing toll of prosperity diseases over 2000–2012 observation period might be attributable to the strong public health legacy of Soviet era as well as reform policies implemented in recent past (32). The rates of hospital discharges increased substantially in the emerging markets across the globe following the increased presence of NCDs in the overall morbidity and mortality structure. This was mainly the case with clinical admissions that could be attributed to the malignant disorders (33) and circulatory diseases (34), followed by chronic obstructive pulmonary diseases (35) and diabetes (36). National level spending on medicines indicated to treat these conditions followed at the same pace, so entire regional pharmaceutical markets adjusted to these changes as was the case in South Eastern Europe (37). Extensive presence of chronic prosperity illnesses supported stronger demand for medical imaging (38), laboratory testing (39), outpatient visits, prescription and dispensing of novel pharmaceuticals (40), surgical, radiation oncology (41), and rehabilitation services. These phenomena were relying on strengthened civil expectations for advanced medical technologies supported by growing living standards and domestic consumption in BRICS markets. If we take into account serious challenge of home-based care for the disabled and growing portion of elderly citizens with special needs, bold growth of national health expenditures should have been predicted (42). China is absolutely leading in terms of purchase power parity of its health spending. Huge lag of all other major emerging economies behind People’s Republic of China is most obvious when compared to the India, rapidly developing nation of a similar population size. Table 1 Non-communicable diseases burden-related indicators; WHO estimates for BRICS in 2000 and 2012; total health expenditure and out-of-pocket health expenditure in terms of current international $ purchase power parity basis (source: Global Health Expenditure Database). Brazil Russian federation India China South Africa 2000 2012 2000 2012 2000 2012 2000 2012 2000 2012 Population (millions) 174.5 198.6 146.8 143.2 1,042.3 1,236.7 1,287.7 1,384.8 44.8 52.4 Years of Life Lost [YLL (′000)]* 22,532 24,915 44,566 40,597 150,751 175,435 165,905 186,591 5,534 7,398 Years Lost due to Disability [YLD (′000)]** 14,600 18,077 16,586 16,206 78,150 96,886 84,450 99,877 3,436 4,233 Disability-Adjusted Life Year [DALY (′000)]*** 37,132 42,992 61,152 56,803 228,901 272,321 250,355 286,468 8,970 11,631 Estimated deaths (′000) NCDs caused, both sexes 777 978 1,819 1,801 4,579 5,869 6,839 8,577 176 264 Total expenditure on health (in million current $ PPP) $87,681 $220,240 $54,200 $211,008 $68,816 $193,969 $138,131 $664,644 $24,728 $51,458 Out of pocket expenditure (in million current $PPP) $33,277 $68,168 $16,242 $72,417 $46,771 $111,673 $81,469 $228,245 $3,227 $3,695 *WHO estimated Years of Life Lost (YLL) due to premature mortality NCDs caused, both sexes (′000). **WHO estimated Years Lost due to Disability (YLD) for people living with NCDs or its consequences (′000). ***WHO estimated Disability-Adjusted Life Year (DALY) NCDs caused, both sexes (′000). Catastrophic household expenditure presents particularly crucial issue throughout the countries of Sudanese Africa with very low incomes, whose medical care is dominantly supported by out-of-pocket spending (43). This happens due to absence of strong national health insurance funds whose revenues would come out of mandatory taxation supported by governmental and external financial sources. Huge, occasionally sevenfold growth of out-of-patient expenditure is clearly visible among the top BRICS markets. Such socioeconomic vulnerability seriously affects the poor members of the community. This might be the crucial issue for long-term affordability (44) of medical care to the ordinary citizens because almost all of the emerging markets own massive rural populations. Urbanization process, which began in Europe in 18th century, is still rapidly evolving throughout Asia, Africa, and Latin America (45). Extensive development of medical facilities network covering remote areas will remain one of the key difficulties for national governments. This is worsened by inevitable concentration of most professional staff in large cities with much more rewarding personal career opportunities. The primary goal for the future of these health systems wiil be provision of accessible medical care. It should have decent quality supported by universal health insurance coverage and full reimbursement of at least essential medicines. The speed of economic growth, political stability, and effectiveness of health reforms remain highly diverse among the top 20 emerging markets. Some global forecasting agencies as well as international financial organizations were pointing out that some smaller scale N-11 economies were top performers on some criteria. Nevertheless, the prevailing consensus is that BRICS (46) health care markets will inevitably outpace all others and remain well ahead of their competition shaping the global health challenges in the first half of 21st century. Conflict of Interest Statement The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Growth of Global Health Spending Share in Low and Middle Income Countries

            Historical patterns of global health spending Over the past century medical technology has provided bold gains extending human longevity for almost several decades in most welfare economies worldwide. These public health victories came at the cost of huge increase in health spending. The USA, the largest health care market where total health expenditure (THE) grew from 4% of GDP to 15%, may serve as an example of such changes. The secular trend consisting of rising wages and incomes constitutes major factor in the rising resources dedicated to the medical care. Business cycle booms and recessions affected health care spending slowly and with a significant lag. In this sense health expenditures should not be compared to short term, quarterly or yearly fluctuations in Gross Domestic Product (GDP) but correlates well to “smoothed” income over the previous 3–6 years (Getzen, 1990). Growth of health expenditure is driven by several underlying issues: population birth rates, per-capita income, inflation and so called “excess growth” that is mostly explained by medical technology advances or increased patient demand for services. This “excess growth” is responsible for raising the share of health care in national GDP, and thus challenging fiscal sustainability. Evidence of excess growth is seen in health insurance premiums that persistently rise faster than tax revenues or wages. Isolated excess cost growth was the key underlying reason for the surmountable surge in health care costs visible in the United States since the late 1950s. Unlike the contemporary post WWII era, previous historical records testify of stable medical costs of about 4% of GDP from 1929 to the late 1950s. U.S. Census records of employment in clinical medicine and published consumer expenditure evidence from 1850–1950 show that these costs were mostly keeping pace with wages. If they were slightly exceeding wages it was only about 0.5% annually thus it took more than a century for them to double, much slower than the quadrupling from 1960 to 2000 (Getzen, 2000). Major causes of such a sudden rise in health expenditures were huge economic development, distinctively extended longevity, control of contagious diseases, rising availability of income used to fund research in medicine, effective financing instruments, and ultimately significant discoveries in medical technologies that supported public willingness for further investment into potential novel biological drugs, implants, robotic surgery, radiation therapy, organ transplants, and other wonder technologies (Getzen, 2014). With several decades delay, due to dissemination of knowledge and improved societal welfare across the globe, similar developments began at the far smaller scale in a large number of low and middle income world economies. Among 160 such nations in the beginning of 1990s long term trends have revealed 16 countries which made greater investments in health care and its core outcomes than most comparable nations. These countries were described by Goldman-Sachs as the world's leading emerging markets. They are listed under the acronyms BRICS (Brazil, Russia, India, China, South Africa) and Next Eleven (N-11: Bangladesh, Egypt, Indonesia, Iran, South Korea, Mexico, Nigeria, Pakistan, the Philippines, Turkey, and Vietnam). This ongoing evolution will most likely shape the appearance of global demand and supply of medical services in XXI century and we believe that therefore it deserves closer examination. Growth of health care spending in low and middle income countries since 1995 The last two decades have been particularly dynamic due to ending the Cold War and accelerated pace of globalization. Contemporary evolution was promising for most nations with average world THE rising from 5.7 to 6.8% GDP [a 19.3% gain or approximately 1% yearly increase over 19 years (Table 1)]. Since 1995 World Health Organization (WHO) has established and disseminated National Health Accounts (NHA) system worldwide. These efforts allowed reliable international comparison of financial flows among national health systems with diverse historical legacies. The World Bank (WB) introduced the measure of gross national income (GNI) classification of countries in 1987 with their Atlas method and GNI per capita indexed in US$ currency (World Bank Income Groups, 2015). Availability of national income per capita strongly influences health expenditure. The correlation is straightforward with a secular trend visible in long time horizons in most world regions. We applied historical lists of WB income classification to reveal patterns in global health spending. Participation of 160 low and middle income countries (as defined by WB in 1995) in global health spending (in million const. 2005 $US) was 10.7%. Nineteen years later the world was a much different place. Global welfare of nations recorded bold increases while 23 countries crossed the WB threshold for high income economies. The remaining 137 low and middle income countries (as defined by WB in 2013) were now spending 14.6% of global THE expressed in millions of constant 2005 $US. The landscape of national medical spending has evolved in favor of developing regions. The 160 countries classified as low and middle by WB in 1995 grew from 26.1% of global THE in 1995 to 39.7% in 2013. While high income economies still dominate the global landscape of medical spending, the growth of emerging economies has reduced their share of the total. Table 1 Transformation of Global Total Health Expenditure (THE) 1995–2013. Table based on WHO National Health Accounts data 1995–2013; Classification based on World Bank Historical Lists of Income level country groups 1995/2013 based on GNI per capita in US$ (Atlas methodology); Top tier Emerging Markets definition adopted based on Goldman-Sachs acronyms BRICs and Next-11. *WB Note: Income classifications are set each year on July 1 for all World Bank member economies, and all other economies with populations of more than 30,000. These official analytical classifications are fixed during the World Bank's fiscal year (ending on June 30), thus economies remain in the categories in which they are classified irrespective of any revisions to their per capita income data. The historical classifications used are as published on July 1 of each fiscal year. **Total of 13 countries/legal entities were not classified according to WB Income groups while three countries ceased to exist in 1995. In 2013 there were two of such non-classified entities listed together with five countries that ceased to exist. ***For a total of 18 countries inclusive of Japan 2013 data are still not released officially therefore closest year available (2012 data in most cases) was used. Joint total health expenditure of these countries excluding Japan remains significantly below 1% of global THE. ****Among the BRICS and Next–11 emerging markets THE data expressed in terms of constant 2005 $US are lacking for Russian Federation and Pakistan for the entire 19 years long observation period and therefore inclusion of this indicator among the emerging markets was omitted entirely due to absence of data for two large nations. Causes of changes and leadership of BRICs + next-11 emerging nations Jim O'Neil's grouping of BRICs was driven primarily designating those whose nominal and purchase power parity (PPP) adjusted GDP growth rates significantly outpaced those of most OECD nations before and during the worldwide economic recession. Similar ongoing development characterizes another group, identified by Goldman-Sachs' as the “Next Eleven.” Profound changes with deep and lasting impact to the global demand for and provision of healthcare services and associated expenditure have occurred. Rapid expansion of civil middle class in most of these societies has been a major underlying factor (Jakovljevic, 2015). Substantial gains in overall welfare are reflected in the expansion of health insurance coverage and diversity of medical services provided. Growth of purchasing power effectively improved affordability of advanced medical care that remains out-of-pocket expense. We witness continuing movement of global growth in health care markets from the established mature economies toward the emerging ones. Slower economic growth in most saturated high-income markets is a contributing factor. Consumer demand for medical services remains larger in traditional wealthy countries, but their share has been decreasing steadily for at least two decades. Total amount of health care spending among BRICS and Next-11 nations became approximately six fold stronger since 1995. Share of Global Health Spending (million current US$) of these emerging nations grew almost two and a half times. This pace of development is far faster compared to that of vast majority of remaining low and middle income countries across the globe. If we observe per capita health spending it appears that general government expenditure on health and private expenditure is consistently stronger among BRICS compared to N-11. Such a historical trend was actually present prior to 1990s and spending differentials continued to exist as paths diverted even further in recent years. Out-of-pocket (OOP) expenditure on health is a significant outlier in this regard. Although both country group averages were similar at the start, N-11 OOP spending soon exceeded BRICs. These facts indicate better success rates among the BRICs in terms of reimbursement policies and insurance coverage over the past 20 years (Jakovljevic, 2014). Prospects for the future Observation of health spending trends over 20 years is still insufficient to understand a “medical transformation” taking place in major national health systems worldwide. Limitations to our judgment might be imposed by reliability and comparability of large international datasets as well (Rayne, 2013). Nevertheless contemporary transformation of global health spending lays grounds for some forecasts on likely scenarios for the future. Low and middle income countries are likely to become more relevant contributor to the global health care market in the long run. Minor proportion of these countries will likely become high income economies over the next decade. Vast majority of them will continue to experience serious obstacles to the fiscal feasibility of their national health systems. Crucial challenges will remain population aging, prosperity disease and rapid urbanization leaving vulnerable rural areas. Universal health insurance coverage will still be a distant policy target for most of these governments with the notable exception of Russian Federation (Jakovljevic et al., in press). Large out of pocket expenses and informal payments will leave ordinary citizens, living close to the poverty line, vulnerable to the illness-induced catastrophic household expenditure (McIntyre et al., 2006). In some world regions with still young populations, communicable diseases control and satisfactory maternal and neonatal medical care provision shall still be a long way ahead (Barik and Thorat, 2015). Regardless of all the aforementioned weaknesses of developing world regions, it appears that most successful among these nations will become even more important players in global health arena. Heavily domination of People's Republic of China (He and Meng, 2016) followed by India in medical spending worldwide will exceed that of all other emerging markets combined. As we approach 2050 it is highly likely that financing of health care in top tier emerging nations will converge toward OECD average in terms of its effectiveness and affordability of medical care to the ordinary citizen (Jakovljevic, 2016). Major imperatives for national policy makers shall remain how to achieve universal health coverage, what services would be covered by basic insurance package and at what cost. Future research in the field should primarily be focused on key causes of out-of-pocket medical spending growth, deepening social gap among the rich and poor communities leading to health inequalities and effectiveness of contemporary policies in low and middle income countries. Data report methodology Public data sources used were WHO issued Global Health Expenditure Database relying on NHA records: http://apps.who.int/nha/database/Select/Indicators/en and World Bank (WB) Income Groups; Historical country classifications based on Atlas method: http://data.worldbank.org/about/country-and-lending-groups. Filters applied to these extensive data sources were indicators referring to the national level and Global Total Health Expenditure (THE) expressed in following units: million constant 2005 $US, million current US$, million current PPP international $US and THE percentage share of national Gross Domestic Product available (GDP). Data were acquired based on reported values to the WHO and WB by the national authorities as well as independent assessments and calculations provided by WHO and WB and officially released in respective years. Readers are free to access and reuse these publicly available data at the links provided above. Author contributions MJ and TG have jointly developed the research questions, study design, did all the calculations and prepared manuscript for this Data report. Therefore, they share the first authorship in this paper. Conflict of interest statement The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Resource allocation strategies in Southeastern European health policy.

              The past 23 years of post-socialist restructuring of health system funding and management patterns has brought many changes to small Balkan markets, putting them under increasing pressure to keep pace with advancing globalization. Socioeconomic inequalities in healthcare access are still growing across the region. This uneven development is marked by the substantial difficulties encountered by local governments in delivering medical services to broad sectors of the population. This paper presents the results of a systematic review of the following evidence: published reports on health system reforms in the region commissioned by WHO, IMF, World Bank, OECD, European Commission; all available published evidence on health economics, funding, reimbursement in world/local languages since 1989 indexed at Medline, Excerpta Medica and Google Scholar; in depth analysis of official website data on medical care financing related legislation among key public institutions such as national Ministries of health, Health Insurance Funds, Professional Associations were applicable, in local languages; correspondence with key opinion leaders in the field in their respective communities. Contributors were asked to answer a particular set of questions related to the issue, thus enlightening fresh legislative developments and hidden patterns of policy maker's behavior. Cost awareness is slowly expanding in regional management, academic and industrial establishment. The study provides an exact and comprehensive description of its current extent and legislative framework. Western Balkans policy makers would profit substantially from health-economics-based decision-making to cope with increasing difficulties in funding and delivering medical care in emerging markets with a rapidly growing demand for health services.
                Bookmark

                Author and article information

                Contributors
                Journal
                Front Physiol
                Front Physiol
                Front. Physiol.
                Frontiers in Physiology
                Frontiers Media S.A.
                1664-042X
                23 February 2016
                2016
                : 7
                : 48
                Affiliations
                [1] 1Head of Health Economics and Pharmacoeconomics, The Faculty of Medical Sciences, University of Kragujevac Kragujevac, Serbia
                [2] 2Vice Dean for Integrated Academic Studies of Dentistry, The Faculty of Medical Sciences, University of Kragujevac Kragujevac, Serbia
                [3] 3The Faculty of Medical Sciences, University of Kragujevac Kragujevac, Serbia
                [4] 4Department for Orthodontics, The Faculty of Dentistry, University of Belgrade Belgrade, Serbia
                Author notes

                Edited by: Ivana Gadjanski, Belgrade Metropolitan University, Serbia

                Reviewed by: Debasis Barik, National Council of Applied Economic Research, India; Habib Nawaz Khan, Universiti Teknologi Petronas, Malaysia; Roza Adany, University of Debrecen, Hungary

                This article was submitted to Craniofacial Biology, a section of the journal Frontiers in Physiology

                Article
                10.3389/fphys.2016.00048
                4763169
                26941648
                721ee1d0-f01a-4d2b-81f1-d4c7be50efea
                Copyright © 2016 Jakovljevic, Kanjevac, Lazarevic and Vladimir.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 11 December 2015
                : 02 February 2016
                Page count
                Figures: 0, Tables: 2, Equations: 0, References: 21, Pages: 7, Words: 3910
                Funding
                Funded by: Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja 10.13039/501100004564
                Award ID: OI 175014
                Award ID: OI 175071
                Categories
                Physiology
                Opinion

                Anatomy & Physiology
                oral health,european region,dentist density,capacity building,dmft-12,eu,cis
                Anatomy & Physiology
                oral health, european region, dentist density, capacity building, dmft-12, eu, cis

                Comments

                Comment on this article